North Atlantic Drilling Ltd (NADL) Drops 10.63% on January 06

Equities Staff |

North Atlantic Drilling Ltd (NADL) was one of the Russell 2000's biggest losers for Wednesday January 06 as the stock slid 10.63% to $1.85, a loss of $-0.22 per share. Starting at an opening price of $1.94 a share, the stock traded between $1.80 and $1.99 over the course of the trading day. Volume was 128,363 shares over 425 trades, against an average daily volume of 64,585 shares and a total float of 24.11 million.

The losses send North Atlantic Drilling Ltd down to a market cap of $44.61 million. In the last year, North Atlantic Drilling Ltd has traded between $23.70 and $1.99, and its 50-day SMA is currently $5.35 and 200-day SMA is $9.75.

North Atlantic Drilling Ltd is engaged in providing offshore drilling services to the oil and gas industry. The Company currently operates exclusively in Norway and the United Kingdom.

North Atlantic Drilling Ltd is based out of Hamilton, and has some 1,405 employees. Its CEO is Alf Lovdal.

For a complete fundamental analysis analysis of North Atlantic Drilling Ltd, check out’s Stock Valuation Analysis report for NADL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…